Skip to content
Bored Studies
Recruiting

Enhancing Heart Allograft Function With the OCS Heart System Trial

TransMedics · NCT07145515

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
655
US sites recruiting
7
Study start
January 2026
Record last updated
January 12, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution and OFE compared to Static Cold Storage (SCS) in DBD heart transplantation to potentially demonstrate superiority.

Being studied: OCS Heart; Static Cold Storage (SCS)

Conditions: Heart Transplant

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Part A - DCD Donor Hearts \& DBD Donor Hearts Initially Deemed Unsuitable for Cold Storage (Current Approved Indications):

Donor Inclusion Criteria

  • Donor hearts are deemed clinically acceptable for transplantation after physical examination of the donor hearts in the donor chest and/or on the back table in the donor operating room.
  • All DCD donors eligible for functional warm ischemic time criteria ≤ 30 minutes. WIT defined as time from when mean systolic blood pressure (SBP) is \<50mmHg (sustained for at least 5 minutes) to aortic cross clamp and administration of old cardioplegia in the donor.
  • DBD donor hearts with an expected cross clamp of ≥ 4 hours
  • DBD donor hearts with any of the following organ quality concerns, regardless of cross clamp time:
  • Donor age ≥ 40 years old
  • Unknown downtime
  • Insignificant CAD
  • LVEF ≤ 50%

Donor Exclusion • Moderate to severe aortic incompetence

Part B - DBD Donor Hearts Currently Used with Cold Storage (New Indication):

Donor Inclusion Criteria

  • Donor hearts are deemed clinically acceptable for transplantation after physical examination of the donor hearts in the donor chest and/or on the back table in the donor operating room.
  • Eligible for randomization to OCS or SCS treatment arms.
  • DBD donor hearts with an expected cross clamp time of \< 4 hours.

Donor Exclusion

  • Moderate to severe aortic incompetence
  • DBD donor with any of the following organ quality concerns:
  • Donor age ≥ 40 years old
  • Unknown downtime
  • Insignificant CAD
  • LVEF ≤ 50%

Recipient Eligibility Criteria (for Part A and B Cohorts)

Inclusion

  • Signed informed consent document and authorization to use and disclose protected health information
  • Heart transplant candidate
  • Age ≥ 18 years old

Exclusion

  • Participant in any other interventional clinical or investigational trials/programs that may confound the outcomes of this trial

Recruiting US locations

  • University of California San Francisco

    San Francisco, CA 94143

    Site contact: Imani Dunn · Imani.Robinson@ucsf.edu

  • Tampa General Hospital

    Tampa, FL 33606

    Site contact: Courtney Nicholas · 813-844-4914 · courtneynicholas@tgh.org

  • Massachusetts General Hospital

    Boston, MA 02114

    Site contact: Kamila Drezek · KDREZEK@mgh.harvard.edu

  • Mount Sinai

    New York, NY 10029

    Site contact: Favio Herbas · Favio.Herbas@mountsinai.org

  • Westchester Medical Center

    Valhalla, NY 10595

    Site contact: Corazon De La Pena · 914-493-2483 · Corazon.Delapena@wmchealth.org

  • Duke University

    Durham, NC 27710

    Site contact: Sarah Casalinova · 919-613-5621 · sarah.casalinova@duke.edu

  • Baylor Scott and White

    Dallas, TX 75226

    Site contact: Lesia Parker

Study contacts (from the official record)

  • Raicca Haqqi · 978-809-0620 · rhaqqi@transmedics.com
  • Kausar Qidwai · 978-494-7105 · kqidwai@transmedics.com
Enhancing Heart Allograft Function With the OCS Heart System Trial (NCT07145515) | Bored Studies